Literature DB >> 28779564

The functional significance of 14-3-3 proteins in cancer: focus on lung cancer.

Afshin Khorrami1, Mahyar Sharif Bagheri1, Mahmood Tavallaei1, Javad Gharechahi1.   

Abstract

The 14-3-3 family proteins are phosphoserine/phosphothreonine binding proteins constituting a conserved class of proteins which are detected in all eukaryotic cells. In mammalians, 14-3-3 proteins have seven distinct isoforms (β, γ, ε, η, ζ, σ and τ/θ) which are involved in various cellular processes including signal transduction, cell cycle, cell proliferation, apoptosis, differentiation and survival. 14-3-3 proteins do not have a distinct catalytic activity and often regulate the activity, stability, subcellular localization and interactions of other proteins. The 14-3-3 family proteins function through interacting with their client proteins or facilitating the interaction of other proteins likely as adaptor proteins. The versatile functions of these proteins in the regulation of cell growth, cell division, cell death and cell migration make them candidate proteins for which an important role in cancer development could be envisioned. Indeed, analysis of cancer cell lines and tumor-derived tissues have indicated the differential abundance or post-translational modification of some 14-3-3 isoforms. In this review, we aimed to show how deregulation of 14-3-3 proteins contributes to initiation, establishment and progression of cancers with a particular emphasis on lung cancer. The role of these proteins in cancer-relevant processes including cell cycle, cell migration, cell-cell communication and programmed cell death will be discussed in detail.

Entities:  

Keywords:  14-3-3 proteins; cancer; cell cycle; cell proliferation; lung cancer; protein interaction

Mesh:

Substances:

Year:  2017        PMID: 28779564     DOI: 10.1515/hmbci-2017-0032

Source DB:  PubMed          Journal:  Horm Mol Biol Clin Investig        ISSN: 1868-1883


  13 in total

Review 1.  Evidence-Based Management of Uterine Fibroids With Botanical Drugs-A Review.

Authors:  Masita Arip; Vi Lien Yap; Mogana Rajagopal; Malarvili Selvaraja; K Dharmendra; Sasikala Chinnapan
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

2.  YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.

Authors:  Yan Xu; Mariateresa Fulciniti; Mehmet K Samur; Matthew Ho; Shuhui Deng; Lanting Liu; Kenneth Wen; Tengteng Yu; Zuzana Chyra; Sanika Dereibal; Li Zhang; Yao Yao; Chandraditya Chakraborty; Eugenio Morelli; Na Li; Michael A Lopez; Tommaso Perini; Shidai Mu; Gang An; Rafael Alonso; Giada Bianchi; Yu-Tzu Tai; Kenneth C Anderson; Lugui Qiu; Nikhil C Munshi
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

3.  Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma.

Authors:  Thomas R Holmes; Jenan Al Matouq; Matti Holmes; Natasha Sioda; Justin C Rudd; Celia Bloom; Lauren Nicola; Nicholas Y Palermo; Justin G Madson; Sándor Lovas; Laura A Hansen
Journal:  Carcinogenesis       Date:  2021-02-25       Impact factor: 4.944

4.  Overexpression of 14-3-3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma.

Authors:  Man Li; Hailing Lu; Xiaolian Liu; Qingwei Meng; Yanbin Zhao; Xuesong Chen; Jing Hu; Wei Liu; Li Cai
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

5.  Neural stem cell small extracellular vesicle-based delivery of 14-3-3t reduces apoptosis and neuroinflammation following traumatic spinal cord injury by enhancing autophagy by targeting Beclin-1.

Authors:  Yuluo Rong; Wei Liu; Chengtang Lv; Jiaxing Wang; Yongjun Luo; Dongdong Jiang; Linwei Li; Zheng Zhou; Wei Zhou; Qingqing Li; Guoyong Yin; Lipeng Yu; Jin Fan; Weihua Cai
Journal:  Aging (Albany NY)       Date:  2019-09-28       Impact factor: 5.682

6.  Activation of the Ca2+ sensing receptor and the PKC/WNK4 downstream signaling cascade induces incorporation of ZO-2 to tight junctions and its separation from 14-3-3.

Authors:  Elida Amaya; Lourdes Alarcón; Dolores Martín-Tapia; Francisco Cuellar-Pérez; Misael Cano-Cortina; Jose Mario Ortega-Olvera; Bulmaro Cisneros; Alexis J Rodriguez; Gerardo Gamba; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2019-07-18       Impact factor: 4.138

7.  Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.

Authors:  Dong-Bo Chen; Yang-Jing Zhao; Xue-Yan Wang; Wei-Jia Liao; Pu Chen; Kang-Jian Deng; Xu Cong; Ran Fei; Xu Wu; Qi-Xiang Shao; Lai Wei; Xing-Wang Xie; Hong-Song Chen
Journal:  Chin Med J (Engl)       Date:  2019-07-05       Impact factor: 2.628

8.  Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer.

Authors:  Thomas R Holmes; Jenan Al-Matouq; Matti Holmes; Lauren Nicola; Justin C Rudd; Sándor Lovas; Laura A Hansen
Journal:  Oncotarget       Date:  2020-09-01

9.  FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3β and promotes cell proliferation in squamous cell lung carcinoma.

Authors:  Nan Liu; Haijing Zhou; Xiupeng Zhang; Lin Cai; Jingduo Li; Jing Zhao; Yang Liu; Liang Wang; Chuifeng Fan; Ailin Li; Yuan Miao
Journal:  Onco Targets Ther       Date:  2019-08-13       Impact factor: 4.147

10.  Two-hybrid screening of FAM13A protein partners in lung epithelial cells.

Authors:  Manon Ruffin; Kristin E Thompson; Harriet Corvol; Loic Guillot
Journal:  BMC Res Notes       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.